Institutional investors control 45.58% of the outstanding shares in GERN. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended March 2015, these large investors purchased a net $2.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE AG Bought 9.4 Thousand shares of Geron Corp
LIFESCI INDEX PARTNERS LLC Bought 6.5 Thousand shares of Geron Corp
STATE STREET GLOBAL ADVISORS LTD... Sold 203.00 shares of Geron Corp